Global Androgen Deprivation Therapy (ADT) Market Growth (Status and Outlook) 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Androgen Deprivation Therapy (ADT) will have significant change from previous year. According to our (LP Information) latest study, the global Androgen Deprivation Therapy (ADT) market size is USD million in 2022 from USD 5647.6 million in 2021, with a change of % between 2021 and 2022. The global Androgen Deprivation Therapy (ADT) market size will reach USD 8046.2 million in 2028, growing at a CAGR of 5.2% over the analysis period.
The United States Androgen Deprivation Therapy (ADT) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Androgen Deprivation Therapy (ADT) market, reaching US$ million by the year 2028. As for the Europe Androgen Deprivation Therapy (ADT) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Androgen Deprivation Therapy (ADT) players cover Pfizer, Astellas Pharma, Johnson & Johnson, and Novartis International, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Androgen Deprivation Therapy (ADT) market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
As the global economy mends, the 2021 growth of Androgen Deprivation Therapy (ADT) will have significant change from previous year. According to our (LP Information) latest study, the global Androgen Deprivation Therapy (ADT) market size is USD million in 2022 from USD 5647.6 million in 2021, with a change of % between 2021 and 2022. The global Androgen Deprivation Therapy (ADT) market size will reach USD 8046.2 million in 2028, growing at a CAGR of 5.2% over the analysis period.
The United States Androgen Deprivation Therapy (ADT) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Androgen Deprivation Therapy (ADT) market, reaching US$ million by the year 2028. As for the Europe Androgen Deprivation Therapy (ADT) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Androgen Deprivation Therapy (ADT) players cover Pfizer, Astellas Pharma, Johnson & Johnson, and Novartis International, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Androgen Deprivation Therapy (ADT) market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
- Medicine
- Surgery
- Other
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Astellas Pharma
- Johnson & Johnson
- Novartis International
- Merck
- Veru
- Sanofi
- GlaxoSmithKline
- Bayer
- Orion
- AstraZeneca
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Androgen Deprivation Therapy (ADT) Market Size 2017-2028
2.1.2 Androgen Deprivation Therapy (ADT) Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Androgen Deprivation Therapy (ADT) Segment by Type
2.2.1 Medicine
2.2.2 Surgery
2.2.3 Other
2.3 Androgen Deprivation Therapy (ADT) Market Size by Type
2.3.1 Androgen Deprivation Therapy (ADT) Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Androgen Deprivation Therapy (ADT) Market Size Market Share by Type (2017-2022)
2.4 Androgen Deprivation Therapy (ADT) Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Androgen Deprivation Therapy (ADT) Market Size by Application
2.5.1 Androgen Deprivation Therapy (ADT) Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Androgen Deprivation Therapy (ADT) Market Size Market Share by Application (2017-2022)
3 ANDROGEN DEPRIVATION THERAPY (ADT) MARKET SIZE BY PLAYER
3.1 Androgen Deprivation Therapy (ADT) Market Size Market Share by Players
3.1.1 Global Androgen Deprivation Therapy (ADT) Revenue by Players (2020-2022)
3.1.2 Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Players (2020-2022)
3.2 Global Androgen Deprivation Therapy (ADT) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANDROGEN DEPRIVATION THERAPY (ADT) BY REGIONS
4.1 Androgen Deprivation Therapy (ADT) Market Size by Regions (2017-2022)
4.2 Americas Androgen Deprivation Therapy (ADT) Market Size Growth (2017-2022)
4.3 APAC Androgen Deprivation Therapy (ADT) Market Size Growth (2017-2022)
4.4 Europe Androgen Deprivation Therapy (ADT) Market Size Growth (2017-2022)
4.5 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022)
5.2 Americas Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022)
5.3 Americas Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Androgen Deprivation Therapy (ADT) Market Size by Region (2017-2022)
6.2 APAC Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022)
6.3 APAC Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Androgen Deprivation Therapy (ADT) by Country (2017-2022)
7.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022)
7.3 Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Androgen Deprivation Therapy (ADT) by Region (2017-2022)
8.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022)
8.3 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET FORECAST
10.1 Global Androgen Deprivation Therapy (ADT) Forecast by Regions (2023-2028)
10.1.1 Global Androgen Deprivation Therapy (ADT) Forecast by Regions (2023-2028)
10.1.2 Americas Androgen Deprivation Therapy (ADT) Forecast
10.1.3 APAC Androgen Deprivation Therapy (ADT) Forecast
10.1.4 Europe Androgen Deprivation Therapy (ADT) Forecast
10.1.5 Middle East & Africa Androgen Deprivation Therapy (ADT) Forecast
10.2 Americas Androgen Deprivation Therapy (ADT) Forecast by Country (2023-2028)
10.2.1 United States Androgen Deprivation Therapy (ADT) Market Forecast
10.2.2 Canada Androgen Deprivation Therapy (ADT) Market Forecast
10.2.3 Mexico Androgen Deprivation Therapy (ADT) Market Forecast
10.2.4 Brazil Androgen Deprivation Therapy (ADT) Market Forecast
10.3 APAC Androgen Deprivation Therapy (ADT) Forecast by Region (2023-2028)
10.3.1 China Androgen Deprivation Therapy (ADT) Market Forecast
10.3.2 Japan Androgen Deprivation Therapy (ADT) Market Forecast
10.3.3 Korea Androgen Deprivation Therapy (ADT) Market Forecast
10.3.4 Southeast Asia Androgen Deprivation Therapy (ADT) Market Forecast
10.3.5 India Androgen Deprivation Therapy (ADT) Market Forecast
10.3.6 Australia Androgen Deprivation Therapy (ADT) Market Forecast
10.4 Europe Androgen Deprivation Therapy (ADT) Forecast by Country (2023-2028)
10.4.1 Germany Androgen Deprivation Therapy (ADT) Market Forecast
10.4.2 France Androgen Deprivation Therapy (ADT) Market Forecast
10.4.3 UK Androgen Deprivation Therapy (ADT) Market Forecast
10.4.4 Italy Androgen Deprivation Therapy (ADT) Market Forecast
10.4.5 Russia Androgen Deprivation Therapy (ADT) Market Forecast
10.5 Middle East & Africa Androgen Deprivation Therapy (ADT) Forecast by Region (2023-2028)
10.5.1 Egypt Androgen Deprivation Therapy (ADT) Market Forecast
10.5.2 South Africa Androgen Deprivation Therapy (ADT) Market Forecast
10.5.3 Israel Androgen Deprivation Therapy (ADT) Market Forecast
10.5.4 Turkey Androgen Deprivation Therapy (ADT) Market Forecast
10.5.5 GCC Countries Androgen Deprivation Therapy (ADT) Market Forecast
10.6 Global Androgen Deprivation Therapy (ADT) Forecast by Type (2023-2028)
10.7 Global Androgen Deprivation Therapy (ADT) Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Androgen Deprivation Therapy (ADT) Product Offered
11.1.3 Pfizer Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Information
11.2.2 Astellas Pharma Androgen Deprivation Therapy (ADT) Product Offered
11.2.3 Astellas Pharma Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Astellas Pharma Main Business Overview
11.2.5 Astellas Pharma Latest Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Androgen Deprivation Therapy (ADT) Product Offered
11.3.3 Johnson & Johnson Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Johnson & Johnson Main Business Overview
11.3.5 Johnson & Johnson Latest Developments
11.4 Novartis International
11.4.1 Novartis International Company Information
11.4.2 Novartis International Androgen Deprivation Therapy (ADT) Product Offered
11.4.3 Novartis International Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Novartis International Main Business Overview
11.4.5 Novartis International Latest Developments
11.5 Merck
11.5.1 Merck Company Information
11.5.2 Merck Androgen Deprivation Therapy (ADT) Product Offered
11.5.3 Merck Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Merck Main Business Overview
11.5.5 Merck Latest Developments
11.6 Veru
11.6.1 Veru Company Information
11.6.2 Veru Androgen Deprivation Therapy (ADT) Product Offered
11.6.3 Veru Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Veru Main Business Overview
11.6.5 Veru Latest Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Androgen Deprivation Therapy (ADT) Product Offered
11.7.3 Sanofi Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Sanofi Main Business Overview
11.7.5 Sanofi Latest Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Information
11.8.2 GlaxoSmithKline Androgen Deprivation Therapy (ADT) Product Offered
11.8.3 GlaxoSmithKline Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 GlaxoSmithKline Main Business Overview
11.8.5 GlaxoSmithKline Latest Developments
11.9 Bayer
11.9.1 Bayer Company Information
11.9.2 Bayer Androgen Deprivation Therapy (ADT) Product Offered
11.9.3 Bayer Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Bayer Main Business Overview
11.9.5 Bayer Latest Developments
11.10 Orion
11.10.1 Orion Company Information
11.10.2 Orion Androgen Deprivation Therapy (ADT) Product Offered
11.10.3 Orion Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Orion Main Business Overview
11.10.5 Orion Latest Developments
11.11 AstraZeneca
11.11.1 AstraZeneca Company Information
11.11.2 AstraZeneca Androgen Deprivation Therapy (ADT) Product Offered
11.11.3 AstraZeneca Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 AstraZeneca Main Business Overview
11.11.5 AstraZeneca Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Androgen Deprivation Therapy (ADT) Market Size 2017-2028
2.1.2 Androgen Deprivation Therapy (ADT) Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Androgen Deprivation Therapy (ADT) Segment by Type
2.2.1 Medicine
2.2.2 Surgery
2.2.3 Other
2.3 Androgen Deprivation Therapy (ADT) Market Size by Type
2.3.1 Androgen Deprivation Therapy (ADT) Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Androgen Deprivation Therapy (ADT) Market Size Market Share by Type (2017-2022)
2.4 Androgen Deprivation Therapy (ADT) Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Androgen Deprivation Therapy (ADT) Market Size by Application
2.5.1 Androgen Deprivation Therapy (ADT) Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Androgen Deprivation Therapy (ADT) Market Size Market Share by Application (2017-2022)
3 ANDROGEN DEPRIVATION THERAPY (ADT) MARKET SIZE BY PLAYER
3.1 Androgen Deprivation Therapy (ADT) Market Size Market Share by Players
3.1.1 Global Androgen Deprivation Therapy (ADT) Revenue by Players (2020-2022)
3.1.2 Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Players (2020-2022)
3.2 Global Androgen Deprivation Therapy (ADT) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANDROGEN DEPRIVATION THERAPY (ADT) BY REGIONS
4.1 Androgen Deprivation Therapy (ADT) Market Size by Regions (2017-2022)
4.2 Americas Androgen Deprivation Therapy (ADT) Market Size Growth (2017-2022)
4.3 APAC Androgen Deprivation Therapy (ADT) Market Size Growth (2017-2022)
4.4 Europe Androgen Deprivation Therapy (ADT) Market Size Growth (2017-2022)
4.5 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022)
5.2 Americas Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022)
5.3 Americas Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Androgen Deprivation Therapy (ADT) Market Size by Region (2017-2022)
6.2 APAC Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022)
6.3 APAC Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Androgen Deprivation Therapy (ADT) by Country (2017-2022)
7.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022)
7.3 Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Androgen Deprivation Therapy (ADT) by Region (2017-2022)
8.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022)
8.3 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET FORECAST
10.1 Global Androgen Deprivation Therapy (ADT) Forecast by Regions (2023-2028)
10.1.1 Global Androgen Deprivation Therapy (ADT) Forecast by Regions (2023-2028)
10.1.2 Americas Androgen Deprivation Therapy (ADT) Forecast
10.1.3 APAC Androgen Deprivation Therapy (ADT) Forecast
10.1.4 Europe Androgen Deprivation Therapy (ADT) Forecast
10.1.5 Middle East & Africa Androgen Deprivation Therapy (ADT) Forecast
10.2 Americas Androgen Deprivation Therapy (ADT) Forecast by Country (2023-2028)
10.2.1 United States Androgen Deprivation Therapy (ADT) Market Forecast
10.2.2 Canada Androgen Deprivation Therapy (ADT) Market Forecast
10.2.3 Mexico Androgen Deprivation Therapy (ADT) Market Forecast
10.2.4 Brazil Androgen Deprivation Therapy (ADT) Market Forecast
10.3 APAC Androgen Deprivation Therapy (ADT) Forecast by Region (2023-2028)
10.3.1 China Androgen Deprivation Therapy (ADT) Market Forecast
10.3.2 Japan Androgen Deprivation Therapy (ADT) Market Forecast
10.3.3 Korea Androgen Deprivation Therapy (ADT) Market Forecast
10.3.4 Southeast Asia Androgen Deprivation Therapy (ADT) Market Forecast
10.3.5 India Androgen Deprivation Therapy (ADT) Market Forecast
10.3.6 Australia Androgen Deprivation Therapy (ADT) Market Forecast
10.4 Europe Androgen Deprivation Therapy (ADT) Forecast by Country (2023-2028)
10.4.1 Germany Androgen Deprivation Therapy (ADT) Market Forecast
10.4.2 France Androgen Deprivation Therapy (ADT) Market Forecast
10.4.3 UK Androgen Deprivation Therapy (ADT) Market Forecast
10.4.4 Italy Androgen Deprivation Therapy (ADT) Market Forecast
10.4.5 Russia Androgen Deprivation Therapy (ADT) Market Forecast
10.5 Middle East & Africa Androgen Deprivation Therapy (ADT) Forecast by Region (2023-2028)
10.5.1 Egypt Androgen Deprivation Therapy (ADT) Market Forecast
10.5.2 South Africa Androgen Deprivation Therapy (ADT) Market Forecast
10.5.3 Israel Androgen Deprivation Therapy (ADT) Market Forecast
10.5.4 Turkey Androgen Deprivation Therapy (ADT) Market Forecast
10.5.5 GCC Countries Androgen Deprivation Therapy (ADT) Market Forecast
10.6 Global Androgen Deprivation Therapy (ADT) Forecast by Type (2023-2028)
10.7 Global Androgen Deprivation Therapy (ADT) Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Androgen Deprivation Therapy (ADT) Product Offered
11.1.3 Pfizer Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Information
11.2.2 Astellas Pharma Androgen Deprivation Therapy (ADT) Product Offered
11.2.3 Astellas Pharma Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Astellas Pharma Main Business Overview
11.2.5 Astellas Pharma Latest Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Androgen Deprivation Therapy (ADT) Product Offered
11.3.3 Johnson & Johnson Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Johnson & Johnson Main Business Overview
11.3.5 Johnson & Johnson Latest Developments
11.4 Novartis International
11.4.1 Novartis International Company Information
11.4.2 Novartis International Androgen Deprivation Therapy (ADT) Product Offered
11.4.3 Novartis International Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Novartis International Main Business Overview
11.4.5 Novartis International Latest Developments
11.5 Merck
11.5.1 Merck Company Information
11.5.2 Merck Androgen Deprivation Therapy (ADT) Product Offered
11.5.3 Merck Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Merck Main Business Overview
11.5.5 Merck Latest Developments
11.6 Veru
11.6.1 Veru Company Information
11.6.2 Veru Androgen Deprivation Therapy (ADT) Product Offered
11.6.3 Veru Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Veru Main Business Overview
11.6.5 Veru Latest Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Androgen Deprivation Therapy (ADT) Product Offered
11.7.3 Sanofi Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Sanofi Main Business Overview
11.7.5 Sanofi Latest Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Information
11.8.2 GlaxoSmithKline Androgen Deprivation Therapy (ADT) Product Offered
11.8.3 GlaxoSmithKline Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 GlaxoSmithKline Main Business Overview
11.8.5 GlaxoSmithKline Latest Developments
11.9 Bayer
11.9.1 Bayer Company Information
11.9.2 Bayer Androgen Deprivation Therapy (ADT) Product Offered
11.9.3 Bayer Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Bayer Main Business Overview
11.9.5 Bayer Latest Developments
11.10 Orion
11.10.1 Orion Company Information
11.10.2 Orion Androgen Deprivation Therapy (ADT) Product Offered
11.10.3 Orion Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Orion Main Business Overview
11.10.5 Orion Latest Developments
11.11 AstraZeneca
11.11.1 AstraZeneca Company Information
11.11.2 AstraZeneca Androgen Deprivation Therapy (ADT) Product Offered
11.11.3 AstraZeneca Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 AstraZeneca Main Business Overview
11.11.5 AstraZeneca Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Androgen Deprivation Therapy (ADT) Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Medicine
Table 3. Major Players of Surgery
Table 4. Major Players of Other
Table 5. Androgen Deprivation Therapy (ADT) Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Androgen Deprivation Therapy (ADT) Market Size Market Share by Type (2017-2022)
Table 8. Androgen Deprivation Therapy (ADT) Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Androgen Deprivation Therapy (ADT) Market Size Market Share by Application (2017-2022)
Table 11. Global Androgen Deprivation Therapy (ADT) Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Player (2020-2022)
Table 13. Androgen Deprivation Therapy (ADT) Key Players Head office and Products Offered
Table 14. Androgen Deprivation Therapy (ADT) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Androgen Deprivation Therapy (ADT) Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Androgen Deprivation Therapy (ADT) Market Size Market Share by Regions (2017-2022)
Table 19. Americas Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Androgen Deprivation Therapy (ADT) Market Size Market Share by Country (2017-2022)
Table 21. Americas Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Androgen Deprivation Therapy (ADT) Market Size Market Share by Type (2017-2022)
Table 23. Americas Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Androgen Deprivation Therapy (ADT) Market Size Market Share by Application (2017-2022)
Table 25. APAC Androgen Deprivation Therapy (ADT) Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Androgen Deprivation Therapy (ADT) Market Size Market Share by Region (2017-2022)
Table 27. APAC Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Androgen Deprivation Therapy (ADT) Market Size Market Share by Type (2017-2022)
Table 29. APAC Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Androgen Deprivation Therapy (ADT) Market Size Market Share by Application (2017-2022)
Table 31. Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Androgen Deprivation Therapy (ADT) Market Size Market Share by Country (2017-2022)
Table 33. Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Androgen Deprivation Therapy (ADT) Market Size Market Share by Type (2017-2022)
Table 35. Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Androgen Deprivation Therapy (ADT) Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Androgen Deprivation Therapy (ADT)
Table 44. Key Market Challenges & Risks of Androgen Deprivation Therapy (ADT)
Table 45. Key Industry Trends of Androgen Deprivation Therapy (ADT)
Table 46. Global Androgen Deprivation Therapy (ADT) Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Androgen Deprivation Therapy (ADT) Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Androgen Deprivation Therapy (ADT) Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Androgen Deprivation Therapy (ADT) Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Androgen Deprivation Therapy (ADT) Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Androgen Deprivation Therapy (ADT) Market Size Market Share Forecast by Application (2023-2028)
Table 52. Pfizer Details, Company Type, Androgen Deprivation Therapy (ADT) Area Served and Its Competitors
Table 53. Pfizer Androgen Deprivation Therapy (ADT) Product Offered
Table 54. Pfizer Androgen Deprivation Therapy (ADT) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Pfizer Main Business
Table 56. Pfizer Latest Developments
Table 57. Astellas Pharma Details, Company Type, Androgen Deprivation Therapy (ADT) Area Served and Its Competitors
Table 58. Astellas Pharma Androgen Deprivation Therapy (ADT) Product Offered
Table 59. Astellas Pharma Main Business
Table 60. Astellas Pharma Androgen Deprivation Therapy (ADT) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Astellas Pharma Latest Developments
Table 62. Johnson & Johnson Details, Company Type, Androgen Deprivation Therapy (ADT) Area Served and Its Competitors
Table 63. Johnson & Johnson Androgen Deprivation Therapy (ADT) Product Offered
Table 64. Johnson & Johnson Main Business
Table 65. Johnson & Johnson Androgen Deprivation Therapy (ADT) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Johnson & Johnson Latest Developments
Table 67. Novartis International Details, Company Type, Androgen Deprivation Therapy (ADT) Area Served and Its Competitors
Table 68. Novartis International Androgen Deprivation Therapy (ADT) Product Offered
Table 69. Novartis International Main Business
Table 70. Novartis International Androgen Deprivation Therapy (ADT) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Novartis International Latest Developments
Table 72. Merck Details, Company Type, Androgen Deprivation Therapy (ADT) Area Served and Its Competitors
Table 73. Merck Androgen Deprivation Therapy (ADT) Product Offered
Table 74. Merck Main Business
Table 75. Merck Androgen Deprivation Therapy (ADT) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Merck Latest Developments
Table 77. Veru Details, Company Type, Androgen Deprivation Therapy (ADT) Area Served and Its Competitors
Table 78. Veru Androgen Deprivation Therapy (ADT) Product Offered
Table 79. Veru Main Business
Table 80. Veru Androgen Deprivation Therapy (ADT) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Veru Latest Developments
Table 82. Sanofi Details, Company Type, Androgen Deprivation Therapy (ADT) Area Served and Its Competitors
Table 83. Sanofi Androgen Deprivation Therapy (ADT) Product Offered
Table 84. Sanofi Main Business
Table 85. Sanofi Androgen Deprivation Therapy (ADT) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Sanofi Latest Developments
Table 87. GlaxoSmithKline Details, Company Type, Androgen Deprivation Therapy (ADT) Area Served and Its Competitors
Table 88. GlaxoSmithKline Androgen Deprivation Therapy (ADT) Product Offered
Table 89. GlaxoSmithKline Main Business
Table 90. GlaxoSmithKline Androgen Deprivation Therapy (ADT) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. GlaxoSmithKline Latest Developments
Table 92. Bayer Details, Company Type, Androgen Deprivation Therapy (ADT) Area Served and Its Competitors
Table 93. Bayer Androgen Deprivation Therapy (ADT) Product Offered
Table 94. Bayer Main Business
Table 95. Bayer Androgen Deprivation Therapy (ADT) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Bayer Latest Developments
Table 97. Orion Details, Company Type, Androgen Deprivation Therapy (ADT) Area Served and Its Competitors
Table 98. Orion Androgen Deprivation Therapy (ADT) Product Offered
Table 99. Orion Main Business
Table 100. Orion Androgen Deprivation Therapy (ADT) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Orion Latest Developments
Table 102. AstraZeneca Details, Company Type, Androgen Deprivation Therapy (ADT) Area Served and Its Competitors
Table 103. AstraZeneca Androgen Deprivation Therapy (ADT) Product Offered
Table 104. AstraZeneca Androgen Deprivation Therapy (ADT) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. AstraZeneca Main Business
Table 106. AstraZeneca Latest Developments
Table 1. Androgen Deprivation Therapy (ADT) Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Medicine
Table 3. Major Players of Surgery
Table 4. Major Players of Other
Table 5. Androgen Deprivation Therapy (ADT) Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Androgen Deprivation Therapy (ADT) Market Size Market Share by Type (2017-2022)
Table 8. Androgen Deprivation Therapy (ADT) Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Androgen Deprivation Therapy (ADT) Market Size Market Share by Application (2017-2022)
Table 11. Global Androgen Deprivation Therapy (ADT) Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Player (2020-2022)
Table 13. Androgen Deprivation Therapy (ADT) Key Players Head office and Products Offered
Table 14. Androgen Deprivation Therapy (ADT) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Androgen Deprivation Therapy (ADT) Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Androgen Deprivation Therapy (ADT) Market Size Market Share by Regions (2017-2022)
Table 19. Americas Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Androgen Deprivation Therapy (ADT) Market Size Market Share by Country (2017-2022)
Table 21. Americas Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Androgen Deprivation Therapy (ADT) Market Size Market Share by Type (2017-2022)
Table 23. Americas Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Androgen Deprivation Therapy (ADT) Market Size Market Share by Application (2017-2022)
Table 25. APAC Androgen Deprivation Therapy (ADT) Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Androgen Deprivation Therapy (ADT) Market Size Market Share by Region (2017-2022)
Table 27. APAC Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Androgen Deprivation Therapy (ADT) Market Size Market Share by Type (2017-2022)
Table 29. APAC Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Androgen Deprivation Therapy (ADT) Market Size Market Share by Application (2017-2022)
Table 31. Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Androgen Deprivation Therapy (ADT) Market Size Market Share by Country (2017-2022)
Table 33. Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Androgen Deprivation Therapy (ADT) Market Size Market Share by Type (2017-2022)
Table 35. Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Androgen Deprivation Therapy (ADT) Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Androgen Deprivation Therapy (ADT)
Table 44. Key Market Challenges & Risks of Androgen Deprivation Therapy (ADT)
Table 45. Key Industry Trends of Androgen Deprivation Therapy (ADT)
Table 46. Global Androgen Deprivation Therapy (ADT) Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Androgen Deprivation Therapy (ADT) Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Androgen Deprivation Therapy (ADT) Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Androgen Deprivation Therapy (ADT) Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Androgen Deprivation Therapy (ADT) Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Androgen Deprivation Therapy (ADT) Market Size Market Share Forecast by Application (2023-2028)
Table 52. Pfizer Details, Company Type, Androgen Deprivation Therapy (ADT) Area Served and Its Competitors
Table 53. Pfizer Androgen Deprivation Therapy (ADT) Product Offered
Table 54. Pfizer Androgen Deprivation Therapy (ADT) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Pfizer Main Business
Table 56. Pfizer Latest Developments
Table 57. Astellas Pharma Details, Company Type, Androgen Deprivation Therapy (ADT) Area Served and Its Competitors
Table 58. Astellas Pharma Androgen Deprivation Therapy (ADT) Product Offered
Table 59. Astellas Pharma Main Business
Table 60. Astellas Pharma Androgen Deprivation Therapy (ADT) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Astellas Pharma Latest Developments
Table 62. Johnson & Johnson Details, Company Type, Androgen Deprivation Therapy (ADT) Area Served and Its Competitors
Table 63. Johnson & Johnson Androgen Deprivation Therapy (ADT) Product Offered
Table 64. Johnson & Johnson Main Business
Table 65. Johnson & Johnson Androgen Deprivation Therapy (ADT) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Johnson & Johnson Latest Developments
Table 67. Novartis International Details, Company Type, Androgen Deprivation Therapy (ADT) Area Served and Its Competitors
Table 68. Novartis International Androgen Deprivation Therapy (ADT) Product Offered
Table 69. Novartis International Main Business
Table 70. Novartis International Androgen Deprivation Therapy (ADT) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Novartis International Latest Developments
Table 72. Merck Details, Company Type, Androgen Deprivation Therapy (ADT) Area Served and Its Competitors
Table 73. Merck Androgen Deprivation Therapy (ADT) Product Offered
Table 74. Merck Main Business
Table 75. Merck Androgen Deprivation Therapy (ADT) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Merck Latest Developments
Table 77. Veru Details, Company Type, Androgen Deprivation Therapy (ADT) Area Served and Its Competitors
Table 78. Veru Androgen Deprivation Therapy (ADT) Product Offered
Table 79. Veru Main Business
Table 80. Veru Androgen Deprivation Therapy (ADT) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Veru Latest Developments
Table 82. Sanofi Details, Company Type, Androgen Deprivation Therapy (ADT) Area Served and Its Competitors
Table 83. Sanofi Androgen Deprivation Therapy (ADT) Product Offered
Table 84. Sanofi Main Business
Table 85. Sanofi Androgen Deprivation Therapy (ADT) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Sanofi Latest Developments
Table 87. GlaxoSmithKline Details, Company Type, Androgen Deprivation Therapy (ADT) Area Served and Its Competitors
Table 88. GlaxoSmithKline Androgen Deprivation Therapy (ADT) Product Offered
Table 89. GlaxoSmithKline Main Business
Table 90. GlaxoSmithKline Androgen Deprivation Therapy (ADT) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. GlaxoSmithKline Latest Developments
Table 92. Bayer Details, Company Type, Androgen Deprivation Therapy (ADT) Area Served and Its Competitors
Table 93. Bayer Androgen Deprivation Therapy (ADT) Product Offered
Table 94. Bayer Main Business
Table 95. Bayer Androgen Deprivation Therapy (ADT) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Bayer Latest Developments
Table 97. Orion Details, Company Type, Androgen Deprivation Therapy (ADT) Area Served and Its Competitors
Table 98. Orion Androgen Deprivation Therapy (ADT) Product Offered
Table 99. Orion Main Business
Table 100. Orion Androgen Deprivation Therapy (ADT) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Orion Latest Developments
Table 102. AstraZeneca Details, Company Type, Androgen Deprivation Therapy (ADT) Area Served and Its Competitors
Table 103. AstraZeneca Androgen Deprivation Therapy (ADT) Product Offered
Table 104. AstraZeneca Androgen Deprivation Therapy (ADT) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. AstraZeneca Main Business
Table 106. AstraZeneca Latest Developments
LIST OF FIGURES
Figure 1. Androgen Deprivation Therapy (ADT) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Androgen Deprivation Therapy (ADT) Market Size Market Share by Type in 2021
Figure 7. Androgen Deprivation Therapy (ADT) in Hospital
Figure 8. Global Androgen Deprivation Therapy (ADT) Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Androgen Deprivation Therapy (ADT) in Clinic
Figure 10. Global Androgen Deprivation Therapy (ADT) Market: Clinic (2017-2022) & ($ Millions)
Figure 11. Androgen Deprivation Therapy (ADT) in Other
Figure 12. Global Androgen Deprivation Therapy (ADT) Market: Other (2017-2022) & ($ Millions)
Figure 13. Global Androgen Deprivation Therapy (ADT) Market Size Market Share by Application in 2021
Figure 14. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Player in 2021
Figure 15. Global Androgen Deprivation Therapy (ADT) Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Androgen Deprivation Therapy (ADT) Market Size 2017-2022 ($ Millions)
Figure 17. APAC Androgen Deprivation Therapy (ADT) Market Size 2017-2022 ($ Millions)
Figure 18. Europe Androgen Deprivation Therapy (ADT) Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size 2017-2022 ($ Millions)
Figure 20. Americas Androgen Deprivation Therapy (ADT) Value Market Share by Country in 2021
Figure 21. Americas Androgen Deprivation Therapy (ADT) Consumption Market Share by Type in 2021
Figure 22. Americas Androgen Deprivation Therapy (ADT) Market Size Market Share by Application in 2021
Figure 23. United States Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Androgen Deprivation Therapy (ADT) Market Size Market Share by Region in 2021
Figure 28. APAC Androgen Deprivation Therapy (ADT) Market Size Market Share by Application in 2021
Figure 29. China Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Androgen Deprivation Therapy (ADT) Market Size Market Share by Country in 2021
Figure 36. Europe Androgen Deprivation Therapy (ADT) Market Size Market Share by Type in 2021
Figure 37. Europe Androgen Deprivation Therapy (ADT) Market Size Market Share by Application in 2021
Figure 38. Germany Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size Market Share by Application in 2021
Figure 46. Egypt Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 52. APAC Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 53. Europe Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 55. United States Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 56. Canada Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 59. China Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 60. Japan Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 61. Korea Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 63. India Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 64. Australia Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 65. Germany Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 66. France Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 67. UK Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 68. Italy Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 69. Russia Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 70. Spain Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 73. Israel Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 1. Androgen Deprivation Therapy (ADT) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Androgen Deprivation Therapy (ADT) Market Size Market Share by Type in 2021
Figure 7. Androgen Deprivation Therapy (ADT) in Hospital
Figure 8. Global Androgen Deprivation Therapy (ADT) Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Androgen Deprivation Therapy (ADT) in Clinic
Figure 10. Global Androgen Deprivation Therapy (ADT) Market: Clinic (2017-2022) & ($ Millions)
Figure 11. Androgen Deprivation Therapy (ADT) in Other
Figure 12. Global Androgen Deprivation Therapy (ADT) Market: Other (2017-2022) & ($ Millions)
Figure 13. Global Androgen Deprivation Therapy (ADT) Market Size Market Share by Application in 2021
Figure 14. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Player in 2021
Figure 15. Global Androgen Deprivation Therapy (ADT) Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Androgen Deprivation Therapy (ADT) Market Size 2017-2022 ($ Millions)
Figure 17. APAC Androgen Deprivation Therapy (ADT) Market Size 2017-2022 ($ Millions)
Figure 18. Europe Androgen Deprivation Therapy (ADT) Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size 2017-2022 ($ Millions)
Figure 20. Americas Androgen Deprivation Therapy (ADT) Value Market Share by Country in 2021
Figure 21. Americas Androgen Deprivation Therapy (ADT) Consumption Market Share by Type in 2021
Figure 22. Americas Androgen Deprivation Therapy (ADT) Market Size Market Share by Application in 2021
Figure 23. United States Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Androgen Deprivation Therapy (ADT) Market Size Market Share by Region in 2021
Figure 28. APAC Androgen Deprivation Therapy (ADT) Market Size Market Share by Application in 2021
Figure 29. China Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Androgen Deprivation Therapy (ADT) Market Size Market Share by Country in 2021
Figure 36. Europe Androgen Deprivation Therapy (ADT) Market Size Market Share by Type in 2021
Figure 37. Europe Androgen Deprivation Therapy (ADT) Market Size Market Share by Application in 2021
Figure 38. Germany Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size Market Share by Application in 2021
Figure 46. Egypt Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Androgen Deprivation Therapy (ADT) Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 52. APAC Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 53. Europe Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 55. United States Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 56. Canada Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 59. China Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 60. Japan Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 61. Korea Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 63. India Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 64. Australia Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 65. Germany Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 66. France Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 67. UK Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 68. Italy Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 69. Russia Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 70. Spain Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 73. Israel Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Androgen Deprivation Therapy (ADT) Market Size 2023-2028 ($ Millions)
